ISR
ISR Immune System Regulation Holding AB
European company
Healthcare
Biotechnology
/
NAV Price
-
Last Traded
-
Chg
-
-
XSTO
-
Updated: -
Times are shown in GMT+1, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
/
Company Profile
ISR Immune System Regulation Holding AB is a Sweden based company is engaged in research within the area of immunotherapy. It is principally focused on preclinical and clinical research with the objective to develop novel drugs for curative treatments of viral infections. The group is focused on developing ISR048 technology for the novel treatment of viral infected patients with a focus on human immunodeficiency virus (HIV) infection.ISR Immune System Regulation Holding AB is engaged in research within the area of immunotherapy. It is focused on developing ISR048 technology for the novel treatment of viral infected patients with a focus on HIV infection.
OMX:ISR
SE0008212195
SEK
Loading Comparison
Latest ISR News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News